Purchase Order 75N94019P00723
Award Date
8/15/19
Potential Completion Date
11/18/19
Potential Value
$266K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $201,059.24 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomics analysis instruments and reagents, for an annual NextSeq 550 sequencing instrument service plan. The contract has a base year from April 30, 2022 to April 29, 2023 with four one-year option periods. Illumina is the sole authorized service provider...
This is a $5,216.64 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing systems, reagents, and related services. The award has no set-aside designation. Illumina, a for-profit manufacturer, has previously supported genomic sequencing and analysis efforts across various federal agencies including the NIH, CDC, USDA,...
This firm fixed-price delivery order contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $76,500.00 contract provides Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics...
The Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $145,808.65 award is for the provision of Illumina's proprietary NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated consumables and support services. This award is not...
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $621,584.71 delivery order contract to Illumina, Inc. of San Diego, California. Under the terms of the firm fixed price contract, Illumina will provide NIDDK with NEXTSEQ 500/550 High Output Kits featuring 150 cycle sequencing through December 21, 2021. The place of performance is Illumina's facilities in San Diego. Funding is provided by the Department of Health and Human Services to...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $178,500.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, for the purchase of a NextSeq 500 sequencing system. This award supports the NIH's research and diagnostic needs, as Illumina has provided a range of sequencing systems and consumables to HHS, the Centers for Disease Control and Prevention, the Department of...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, to provide a NextSeq 550 sequencing system and associated support plan. The total potential value of the contract is $392,924.00, with a completion date of September 29, 2025. The contract was awarded on a sole-source basis, with no set-aside...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, for the delivery of an Illumina NextSeq 550 Sequencing System. The potential value of the award is $224,400.00. No set-aside provisions were used. The award was made under a special notice solicitation for an Illumina HiSeq 2500 Sequencer. Illumina has...
The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price delivery order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomics analysis equipment. The $193,926.00 contract, which has a completion date of September 2, 2025, is for the provision of consumables to support NIDDK's research and diagnostic activities. Illumina has a history of federal contract...